1. Home
  2. IPHA vs RITR Comparison

IPHA vs RITR Comparison

Compare IPHA & RITR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPHA
  • RITR
  • Stock Information
  • Founded
  • IPHA 1999
  • RITR 2015
  • Country
  • IPHA France
  • RITR Hong Kong
  • Employees
  • IPHA N/A
  • RITR N/A
  • Industry
  • IPHA Biotechnology: Pharmaceutical Preparations
  • RITR
  • Sector
  • IPHA Health Care
  • RITR
  • Exchange
  • IPHA Nasdaq
  • RITR NYSE
  • Market Cap
  • IPHA 160.1M
  • RITR 166.1M
  • IPO Year
  • IPHA 2019
  • RITR 2024
  • Fundamental
  • Price
  • IPHA $1.98
  • RITR $2.62
  • Analyst Decision
  • IPHA Strong Buy
  • RITR
  • Analyst Count
  • IPHA 1
  • RITR 0
  • Target Price
  • IPHA $11.50
  • RITR N/A
  • AVG Volume (30 Days)
  • IPHA 16.2K
  • RITR 39.4K
  • Earning Date
  • IPHA 03-27-2025
  • RITR 02-15-2025
  • Dividend Yield
  • IPHA N/A
  • RITR N/A
  • EPS Growth
  • IPHA N/A
  • RITR N/A
  • EPS
  • IPHA N/A
  • RITR 0.09
  • Revenue
  • IPHA $20,831,349.00
  • RITR $47,948,887.00
  • Revenue This Year
  • IPHA $220.44
  • RITR N/A
  • Revenue Next Year
  • IPHA $81.85
  • RITR N/A
  • P/E Ratio
  • IPHA N/A
  • RITR $31.23
  • Revenue Growth
  • IPHA N/A
  • RITR 278.44
  • 52 Week Low
  • IPHA $1.29
  • RITR $2.24
  • 52 Week High
  • IPHA $3.51
  • RITR $8.75
  • Technical
  • Relative Strength Index (RSI)
  • IPHA 48.63
  • RITR N/A
  • Support Level
  • IPHA $1.77
  • RITR N/A
  • Resistance Level
  • IPHA $2.03
  • RITR N/A
  • Average True Range (ATR)
  • IPHA 0.08
  • RITR 0.00
  • MACD
  • IPHA -0.01
  • RITR 0.00
  • Stochastic Oscillator
  • IPHA 65.63
  • RITR 0.00

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

About RITR REITAR LOGTECH HLDGS LTD

Reitar Logtech Holdings Ltd provide one-stop solutions for logistics property operations in property development and redevelopment projects. It consists of two segments: construction management and engineering design services; and asset management and professional consultancy services in Hong Kong. Key revenue is generated from construction management and engineering design services.

Share on Social Networks: